While tetrahedranes as a family are scarce, neutral heteroatomic species are all but unknown, with the only reported example being AsP3. Herein, we describe the isolation of a neutral heteroatomic X2Y2 molecular tetrahedron (X, Y=p‐block elements), which also is the long‐sought‐after free phosphaalkyne dimer. Di‐tert‐butyldiphosphatetrahedrane, (tBuCP)2, is formed from the monomer tBuCP in a nickel‐catalyzed dimerization reaction using [(NHC)Ni(CO)3] (NHC=1,3‐bis(2,4,6‐trimethylphenyl)imidazolin‐2‐ylidene (IMes) and 1,3‐bis(2,6‐diisopropylphenyl)imidazolin‐2‐ylidene (IPr)). Single‐crystal X‐ray structure determination of a silver(I) complex confirms the structure of (tBuCP)2. The influence of the N‐heterocyclic carbene ligand on the catalytic reaction was investigated, and a mechanism was elucidated using a combination of synthetic and kinetic studies and quantum chemical calculations.
The reactivity of two paramagnetic nickel(I) compounds, CpNi(NHC) (where Cp=cyclopentadienyl; NHC=1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene (IMes) or 1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene (IPr)), towards [Na(dioxane) ][PnCO] (Pn=P, As) is described. These reactions afford symmetric bimetallic compounds (μ :η ,η -Pn ){Ni(NHC)(CO)} . Several novel intermediates en route to such species are identified and characterised, including a compound containing the PCO anion in an unprecedented μ :η ,η -binding mode. Ultimately, on treatment of the (μ :η ,η -Pn ){Ni(IMes)(CO)} compounds with carbon monoxide, the Pn units can be released, affording P in the case of the phosphorus-containing species, and elemental arsenic in the case of (μ :η ,η -As ){Ni(IMes)(CO)} .
The synthesis of enantioenriched molybdenum precatalysts for the asymmetric hydrogenation of substituted quinolines and naphthalenes is described. Three classes of pincer ligands with chiral substituents were evaluated as supporting ligands in the molybdenumcatalyzed hydrogenation reactions, where oxazoline imino(pyridine) chelates were identified as optimal. A series of 2,6-disubstituted quinolines was hydrogenated to enantioenriched decahydroquinolines with high diastereo-and enantioselectivities. For quinoline derivatives, selective hydrogenation of both the carbocycle and heterocycle was observed depending on the ring substitution. Spectroscopic and mechanistic studies established molybdenum η 6 -arene complexes as the catalyst resting state and that partial hydrogenation arises from dissociation of the substrate from the coordination sphere of molybdenum prior to complete reduction. A stereochemical model is proposed based on the relative energies of the respective coordination of the prochiral faces of the arene determined by steric interactions between the substrate and the chiral ligand, rather than through precoordination by a heteroatom.
The electrophilic character of free diamidocarbenes (DACs) allows them to activate inert bonds in small molecules, such as NH3 and P4 . Herein, we report that metal coordinated DACs also exhibit electrophilic reactivity, undergoing attack by Zn and Cd dialkyl precursors to afford the migratory insertion products [(6-MesDAC-R)MR] (M=Zn, Cd; R=Et, Me; Mes=mesityl). These species were formed via the spectroscopically characterised intermediates [(6-MesDAC)MR2 ], exhibiting barriers to migratory insertion which increase in the order MR2 = ZnEt2 < ZnMe2 < CdMe2 . Compound [(6-MesDAC-Me)CdMe] showed limited stability, undergoing deposition of Cd metal, by an apparent β-H elimination pathway. These results raise doubts about the suitability of diamidocarbenes as ligands in catalytic reactions involving metal species bearing nucleophilic ligands (M-R, M-H).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.